Advertisement

Ads Placeholder
Loading...

Valneva SE

VLA.PAEURONEXT
Healthcare
Biotechnology
2.71
-0.11(-3.97%)
U.S. Market opens in 54h 16m

Valneva SE Fundamental Analysis

Valneva SE (VLA.PA) shows moderate financial fundamentals with a PE ratio of -4.08, profit margin of -65.95%, and ROE of -74.52%. The company generates $0.2B in annual revenue with strong year-over-year growth of 10.32%.

Key Strengths

Cash Position23.33%
PEG Ratio0.42
Current Ratio2.38

Areas of Concern

ROE-74.52%
Operating Margin-50.33%
We analyze VLA.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -103.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-103.8/100

We analyze VLA.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

VLA.PA struggles to generate sufficient returns from assets.

ROA > 10%
-28.88%

Valuation Score

Excellent

VLA.PA trades at attractive valuation levels.

PE < 25
-4.08
PEG Ratio < 2
0.42

Growth Score

Excellent

VLA.PA delivers strong and consistent growth momentum.

Revenue Growth > 5%
10.32%
EPS Growth > 10%
88.48%

Financial Health Score

Moderate

VLA.PA shows balanced financial health with some risks.

Debt/Equity < 1
1.95
Current Ratio > 1
2.38

Profitability Score

Weak

VLA.PA struggles to sustain strong margins.

ROE > 15%
-7451.81%
Net Margin ≥ 15%
-65.95%
Positive Free Cash Flow
No

Key Financial Metrics

Is VLA.PA Expensive or Cheap?

P/E Ratio

VLA.PA trades at -4.08 times earnings. This suggests potential undervaluation.

-4.08

PEG Ratio

When adjusting for growth, VLA.PA's PEG of 0.42 indicates potential undervaluation.

0.42

Price to Book

The market values Valneva SE at 4.43 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.43

EV/EBITDA

Enterprise value stands at -5.41 times EBITDA. This is generally considered low.

-5.41

How Well Does VLA.PA Make Money?

Net Profit Margin

For every $100 in sales, Valneva SE keeps $-65.95 as profit after all expenses.

-65.95%

Operating Margin

Core operations generate -50.33 in profit for every $100 in revenue, before interest and taxes.

-50.33%

ROE

Management delivers $-74.52 in profit for every $100 of shareholder equity.

-74.52%

ROA

Valneva SE generates $-28.88 in profit for every $100 in assets, demonstrating efficient asset deployment.

-28.88%

Following the Money - Real Cash Generation

Operating Cash Flow

Valneva SE generates limited operating cash flow of $-69.07M, signaling weaker underlying cash strength.

$-69.07M

Free Cash Flow

Valneva SE generates weak or negative free cash flow of $-73.52M, restricting financial flexibility.

$-73.52M

FCF Per Share

Each share generates $-0.43 in free cash annually.

$-0.43

FCF Yield

VLA.PA converts -15.89% of its market value into free cash.

-15.89%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.08

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.42

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.43

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.67

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.95

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.38

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.75

vs 25 benchmark

ROA

Return on assets percentage

-0.29

vs 25 benchmark

ROCE

Return on capital employed

-0.29

vs 25 benchmark

How VLA.PA Stacks Against Its Sector Peers

MetricVLA.PA ValueSector AveragePerformance
P/E Ratio-4.0828.45 Better (Cheaper)
ROE-74.52%763.00% Weak
Net Margin-65.95%-45265.00% (disorted) Weak
Debt/Equity1.950.34 Weak (High Leverage)
Current Ratio2.382795.60 Strong Liquidity
ROA-28.88%-16588.00% (disorted) Weak

VLA.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Valneva SE's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-15.39%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-342.17%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-865.49%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ